(Q38451690)

3 September 2017

title

The prognostic value of p53 and DNA ploidy following radical prostatectomy (English)

1 reference

3 September 2017

Deliveliotis C

1

1 reference

3 September 2017

Skolarikos A

2

1 reference

3 September 2017

Karayannis A

3

1 reference

3 September 2017

Tzelepis V

4

1 reference

3 September 2017

Trakas N

5

1 reference

3 September 2017

Alargof E

6

1 reference

3 September 2017

Protogerou V

7

1 reference

3 September 2017

publication date

3 July 2003

1 reference

3 September 2017

published in

World Journal of Urology

1 reference

3 September 2017

volume

21

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

171-176

1 reference

Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy

3 September 2017

cites work

1 reference

12 December 2020

Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999.

1 reference

12 December 2020

p53 and bcl-2 immunohistochemistry in preoperative biopsies as predictors of biochemical recurrence after radical prostatectomy

1 reference

12 December 2020

p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate

1 reference

12 December 2020

Risk factors for progression in patients with prostate cancer treated with radical prostatectomy.

1 reference

12 December 2020

Stage B Prostate Cancer: Correlation of DNA Ploidy Analysis With Histological and Clinical Parameters

1 reference

12 December 2020

Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate

1 reference

12 December 2020

Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer

1 reference

12 December 2020

The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy

1 reference

12 December 2020

An uncertain role for p53 gene alterations in human prostate cancers

1 reference

12 December 2020

National Patterns of Prostate Cancer Treatment by Radical Prostatectomy: Results of a Survey by the American College of Surgeons Commission on Cancer

1 reference

12 December 2020

An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer

1 reference

12 December 2020

Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer

1 reference

12 December 2020

p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy

1 reference

12 December 2020

p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting

1 reference

12 December 2020

Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology

1 reference

12 December 2020

Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy

1 reference

12 December 2020

p53 oncogene mutations in three human prostate cancer cell lines

1 reference

12 December 2020

[Prognostic value of DNA ploidy in prostatic cancer].

1 reference

12 December 2020

Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma

1 reference

12 December 2020

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy

1 reference

12 December 2020

10.1007/S00345-003-0345-0

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1011290380

0 references

1 reference